Unique ID issued by UMIN | UMIN000006066 |
---|---|
Receipt number | R000007127 |
Scientific Title | Patho-physiology of Human Brown Adipose Tissue |
Date of disclosure of the study information | 2011/08/10 |
Last modified on | 2023/02/07 07:47:31 |
Patho-physiology of Human Brown Adipose Tissue
Patho-physiology of Human BAT
Patho-physiology of Human Brown Adipose Tissue
Patho-physiology of Human BAT
Japan |
Healthy subjects
Not applicable | Adult | Child |
Others
NO
Body weight and adiposity are modulated by brown adipose tissue (BAT). Uncoupling protein 1 (UCP1) of the BAT is involved in peripheral thermogenesis and energy expenditure under the control of sympathetic nervous system.
Recently, it was revealed that the BAT plays an important role even in human energy metabolism in the studies of positron-emission tomography and computed tomography (PETCT). Because of the function of human BAT shows the massive glucose uptake ratio compared to skeletal muscles and white adipose tissue (WAT) in the PETCT studies, the evaluation of BAT glucose uptake ratio (such as SUVmax) will be a clear indicator of BAT activity.
Previous studies had managed the results of the SUVmax as an indicator of BAT function at the stimulated state such as cold exposure. However, little studies had marked the results of the SUVmax at a resting state with warm condition.
In this study, we will reevaluate the PETCT medical examination of healthy subjects using PETCT and plain CT in association with the anthropometry, blood biochemistry study, serological study, body fat distribution and glucose/lipid metabolism. We will reach the insight into the accurate manner of regulation relevant to many modulators in various condition of BAT in our research.
Efficacy
Exploratory
Pragmatic
Not applicable
SUVmax and HU of BAT, WAT and skeletal muscle, Visceral fat area, Subcutaneous fat area, VS ratio, hemogram, liver function, glucose metabolism, lipid metabolism, amino acid metabolism.
Observational
Not applicable |
Not applicable |
Male and Female
1) 3,000 healthy subjects who agreed with the study in a document.
1) The subjects taking psychotropic drugs.
2) The subjects taking anti-diabetic drugs.
3) The subjects taking endocrine-modulating drugs.
4) The subjects who had malignant neoplasm disease.
5) The subject who received only either PETCT study or blood biochemistry study.
6) The subject of over 200 mg/dl blood glucose.
7) The restless subject before study.
8) The subject suffering obvious illness.
9) The subject getting pregnant.
10) The subject who was counted as an inappropriate case by researchers.
3000
1st name | Seiichi |
Middle name | |
Last name | Chiba |
Oita University, Faculty of Medicine
Anatomy
8795593
1-1, Idaigaoka, Hazama, Yufu, Oita, Japan
097-586-5623
schiba@oita-u.ac.jp
1st name | Seiichi |
Middle name | |
Last name | Chiba |
Oita University, Faculty of Medicine
Anatomy
8795593
1-1, Idaigaoka, Hazama, Yufu, Oita, Japan
097-586-5623
schiba@oita-u.ac.jp
Shonin Hospital, Shoninkai Medical Corporation.
Oita University, Faculty of Medicine
Self funding
Oita University, Faculty of Medicine, Anatomy
1-1, Idaigaoka, Hazama, Yufu, Oita, Japan
0975865623
schiba@oita-u.ac.jp
NO
2011 | Year | 08 | Month | 10 | Day |
Unpublished
100
Delay expected |
Now writing.
No longer recruiting
2011 | Year | 07 | Month | 01 | Day |
2010 | Year | 07 | Month | 23 | Day |
2011 | Year | 08 | Month | 01 | Day |
2015 | Year | 03 | Month | 31 | Day |
Retrospective observational study
Case control study
2011 | Year | 07 | Month | 29 | Day |
2023 | Year | 02 | Month | 07 | Day |
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000007127